Stability-Indicating HPLC Method for the Simultaneous Determination of HIV Tablet Containing Emtricitabine, Tenofovir Disoproxil Fumarate, and Rilpivirine Hydrochloride in Pharmaceutical Dosage Forms

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/isrn/volume-2014/849149/figures/849149.fig.001a.svgz" name="849149.fig.001a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>Tenofovir</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/isrn/volume-2014/849149/figures/849149.fig.001b.svgz" name="849149.fig.001b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Emtricitabine</td></tr><tr class="fig-image" id="c"><td><object data="https://static.hindawi.com/articles/isrn/volume-2014/849149/figures/849149.fig.001c.svgz" name="849149.fig.001c" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(c) </b>Rilpivirine</td></tr></table>

<div>Chemical structure of analytes: (a) tenofovir, (b) emtricitabine, and (c) rilpivirine.</div>

International Scholarly Research Notices

fig1

Figure 1

Figure 1: Stability-Indicating HPLC Method for the Simultaneous Determination of HIV Tablet Containing Emtricitabine, Tenofovir Disoproxil Fumarate, and Rilpivirine Hydrochloride in Pharmaceutical Dosage Forms 

Figure 1 | Stability-Indicating HPLC Method for the Simultaneous Determination of HIV Tablet Containing Emtricitabine, Tenofovir Disoproxil Fumarate, and Rilpivirine Hydrochloride in Pharmaceutical Dosage Forms 